Latest Venus Remedies stock price

Venus Remedies P/E Ratio

VENUSREM • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
14.27
Low Valuation
Low - May indicate good value opportunity

Current Valuation Metrics

P/E Ratio 14.27
Current Price ₹691.15
EPS (TTM) ₹33.90
Exchange NSE

Valuation Signal

Signal Fairly Valued
Historical Avg 13.33
Historical Range 6.96 - 18.69
Percentile 50.0%

Sector Context

Sector Average 53.7
Sector Median 31.12
Sector Rank #11 of 131
Sector Percentile 8.4%

Earnings Breakdown (TTM)

TTM EPS ₹40.58
Sept 2025 ₹15.06
Mar 2025 ₹15.71

Key P/E Ratio Insights for Venus Remedies

  • Stock appears undervalued with PE of 14.27, suggesting potential buying opportunity
  • Trading at discount to sector average PE of 53.7

View the VENUSREM equity price for detailed stock performance.

P/E Ratio Historical Trend for Venus Remedies

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2024 12.28 26.07 ₹320.15 BSE Low
2023 18.69 21.72 ₹405.95 BSE Moderate
2022 15.38 11.78 ₹181.15 BSE Moderate
2021 6.96 58.85 ₹409.60 BSE Low

Sector P/E Ratio Comparison

Comparing Venus Remedies with other companies in Healthcare sector
Sector Average
53.7
Sector Median
31.12
Lowest P/E
1.5
Highest P/E
628.04
Companies
131
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 1.5 ₹51 Low
Ind Swift Laboratories INDSWFTLAB 3.18 ₹733 Low
Murae Organisor MURAE 3.86 ₹55 Low
Fermenta Biotech FERMENTA 9.01 ₹1,010 Low
Zenith Drugs ZENITHDRUG 9.06 ₹84 Low
Galaxy Medicare GML 9.5 ₹32 Low
Balaxi Pharmaceuticals BALAXI 10.06 ₹139 Low
Natco Pharma NATCOPHARM 10.8 ₹17,006 Low
Vasundhara Rasayans VRL 11.3 ₹51 Low
Mohini Health & Hygiene MHHL 11.84 ₹69 Low